RxSight (RXST) Interest & Investment Income (2020 - 2026)

RxSight has reported Interest & Investment Income for 7 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 22.09% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.8 million (down 15.56% YoY), and the FY2025 full-year result was $9.3 million, down 1.5% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $2.0 million, down from $2.2 million in the prior quarter.
• The five-year high for Interest & Investment Income was $2.9 million in Q3 2024, with the low at $46000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $1.7 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2022 — Interest & Investment Income soared 8260.0% — and 2026, when it slipped 22.09%.
• RxSight's Interest & Investment Income stood at $836000.0 in 2022, then surged by 98.68% to $1.7 million in 2023, then soared by 62.97% to $2.7 million in 2024, then slipped by 18.91% to $2.2 million in 2025, then slipped by 10.98% to $2.0 million in 2026.
• The last three Interest & Investment Income figures came in at $2.0 million (Q1 2026), $2.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.